NCT07023003View on ClinicalTrials.gov

Postpartum Evaluation of Nifedipine and Enalapril for Hypertension

PHASE4RecruitingINTERVENTIONAL
Enrollment

850

Participants

Timeline

Start Date

July 11, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

December 31, 2028

Conditions
Hypertension in Pregnancy
Interventions
DRUG

Enalapril 10mg QD

Enalapril 10mg PO QD will be given to manage postpartum hypertension. Duration of treatment to be dictated by primary provider.

DRUG

Nifedipine 30mg XL BID

Nifedipine 30mg XL BID will be given to manage postpartum hypertension. Duration of treatment to be dictated by primary provider.

Trial Locations (1)

68022

RECRUITING

Methodist Women's Hospital, Omaha

All Listed Sponsors
collaborator

Methodist Hospital Foundation

UNKNOWN

lead

Nebraska Methodist Health System

OTHER